Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, Shunxi will have licence to develop, manufacture, and commercialise CTH-004 to treat several solid tumours including ovarian cancer in Greater China, including Hong Kong, Taiwan, Mainland China, and Macao. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

Manufacturing 52

Manufacturing Patients Leads Pharmaceutical 52

Pharmaceutical Technology

DECEMBER 15, 2022

The US is set to dominate the cardiomyopathy landscape because of the country’s high prevalence of dilated cardiomyopathy (DCM) relative to the other markets in the 7MM, as well as the higher price tag on US-marketed therapeutics. The second highest contributing market is APAC, generating 33.2%

Marketing 52

Marketing Sales Healthcare Healthcare 52

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. This is closely followed by CB2 receptors in second place. This is followed by epilepsy at 8% of the pipeline and multiple sclerosis at 7% of the pipeline.

Medical 98

Medical Specialization Marketing Leads 98

Pharmaceutical Technology

MAY 2, 2023

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Despite the significant advances that have been made in the IO field, a huge level of unmet need remains.

Physicians 52

Physicians Marketing Patients Manufacturing 52

pharmaphorum

NOVEMBER 27, 2022

In recent years, the UK pharmaceutical industry has relied heavily on China and India as providers of active pharmaceutical ingredients. Here’s how applying automaton in pharmaceutical labs can help address these. Reducing capacity issues.

Pharma 101

Pharma Safety Pharmaceutical Manufacturing 101

Clarivate

JULY 27, 2023

We studied patent landscape of XG(S)-PON technology by performing manual analysis of related patents to identify standard relevant patent families and tagging them into one or more technical categories identified based on ITU-T XG(S)-PON standard. We also studied patent distribution in Mainland China, Europe, or the U.S. [1]

Networking 52

Networking Distribution Media Management 52

Pharmaceutical Technology

MARCH 17, 2023

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Marketing 102

Marketing Pharma Pharmaceutical Healthcare 102